![FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is developing a vaccine against the coronavirus, in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder/File Photo](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/CK4DCI4YPTKELFQWX4O5IGKGEU.jpg?smart=true&auth=a3428c11be86230609da12db10793004bebfc8a98d1ddc2659ccdb72d651fe56&width=400&height=225)
Moderna's efforts to develop a vaccine against the coronavirus has fuelled its stock rally. Reuters
Moderna's efforts to develop a vaccine against the coronavirus has fuelled its stock rally. Reuters
Moderna’s stock rally costs short sellers $1.5bn in 2020
The stock price could rise higher as the company starts a final-stage study of the vaccine this month